These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18978145)

  • 21. Extensively drug-resistant tuberculosis.
    Madariaga MG; Lalloo UG; Swindells S
    Am J Med; 2008 Oct; 121(10):835-44. PubMed ID: 18823850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis.
    Martin A; Paasch F; Docx S; Fissette K; Imperiale B; Ribón W; González LA; Werngren J; Engström A; Skenders G; Juréen P; Hoffner S; Del Portillo P; Morcillo N; Palomino JC
    J Antimicrob Chemother; 2011 Apr; 66(4):827-33. PubMed ID: 21393176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
    Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
    Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
    Villar M; Sotgiu G; D'Ambrosio L; Raymundo E; Fernandes L; Barbedo J; Diogo N; Lange C; Centis R; Migliori GB
    Eur Respir J; 2011 Sep; 38(3):730-3. PubMed ID: 21885418
    [No Abstract]   [Full Text] [Related]  

  • 26. Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes.
    Tang S; Zhang Q; Yu J; Liu Y; Sha W; Sun H; Fan L; Gu J; Hao X; Yao L; Xiao H
    Scand J Infect Dis; 2011 Apr; 43(4):280-5. PubMed ID: 21247226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target regimen profiles for treatment of tuberculosis: a WHO document.
    Lienhardt C; Nahid P; Rich ML; Bansbach C; Kendall EA; Churchyard G; González-Angulo L; D'Ambrosio L; Migliori GB; Raviglione M
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28122858
    [No Abstract]   [Full Text] [Related]  

  • 28. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 30. Extensively drug-resistant Mycobacterium tuberculosis from aspirates, Rural South Africa.
    Heysell SK; Moll AP; Gandhi NR; Eksteen FJ; Babaria P; Coovadia Y; Roux L; Lalloo U; Friedland G; Shah NS
    Emerg Infect Dis; 2010 Mar; 16(3):557-60. PubMed ID: 20202446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDR, XDR, TDR tuberculosis: ominous progression.
    Udwadia ZF
    Thorax; 2012 Apr; 67(4):286-8. PubMed ID: 22427352
    [No Abstract]   [Full Text] [Related]  

  • 32. Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium.
    Blasi F; Dara M; van der Werf MJ; Migliori GB
    Eur Respir J; 2013 Mar; 41(3):491-4. PubMed ID: 23456928
    [No Abstract]   [Full Text] [Related]  

  • 33. Multidrug resistant tuberculosis: a growing public health threat.
    Salahuddin N
    J Coll Physicians Surg Pak; 2009 Sep; 19(9):537-8. PubMed ID: 19728935
    [No Abstract]   [Full Text] [Related]  

  • 34. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
    Fattorini L; Migliori GB; Cassone A
    Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A high prevalence of resistance in new tuberculosis cases of midwestern Brazil.
    Santos LC; Bousquet Hde M; Pereira AM; Junqueira-Kipnis AP; Kipnis A
    Infect Genet Evol; 2010 Oct; 10(7):1052-7. PubMed ID: 20619356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.
    Chen L; Li N; Liu M; Zhang J; Zhang H
    J Antimicrob Chemother; 2011 Oct; 66(10):2435-7. PubMed ID: 21795258
    [No Abstract]   [Full Text] [Related]  

  • 37. Multidrug-resistant and extensively drug-resistant tuberculosis: a review.
    Chan ED; Iseman MD
    Curr Opin Infect Dis; 2008 Dec; 21(6):587-95. PubMed ID: 18978526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
    Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
    J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
    Koenig R
    Science; 2008 Feb; 319(5865):894-7. PubMed ID: 18276863
    [No Abstract]   [Full Text] [Related]  

  • 40. Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
    Ramos E; Fissette K; de Rijk P; Palomino JC; Martin A
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):110-3. PubMed ID: 22236855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.